194 related articles for article (PubMed ID: 3326213)
1. Enteric coated microspheres of pancreatin in the treatment of cystic fibrosis: comparison with a standard enteric coated preparation.
Stead RJ; Skypala I; Hodson ME; Batten JC
Thorax; 1987 Jul; 42(7):533-7. PubMed ID: 3326213
[TBL] [Abstract][Full Text] [Related]
2. Treatment of steatorrhoea in cystic fibrosis: a comparison of enteric-coated microspheres of pancreatin versus non-enteric-coated pancreatin and adjuvant cimetidine.
Stead RJ; Skypala I; Hodson ME
Aliment Pharmacol Ther; 1988 Dec; 2(6):471-82. PubMed ID: 2979269
[TBL] [Abstract][Full Text] [Related]
3. A comparison of enteric coated microspheres with enteric coated tablet pancreatic enzyme preparations in cystic fibrosis. A controlled study.
Vyas H; Matthew DJ; Milla PJ
Eur J Pediatr; 1990 Jan; 149(4):241-3. PubMed ID: 1689245
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
Ansaldi-Balocco N; Santini B; Sarchi C
J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938
[TBL] [Abstract][Full Text] [Related]
5. Two enteric coated microspheres in cystic fibrosis.
Williams J; MacDonald A; Weller PH; Fields J; Pandov H
Arch Dis Child; 1990 Jun; 65(6):594-7. PubMed ID: 2198848
[TBL] [Abstract][Full Text] [Related]
6. A comparison of two pancreatin microsphere preparations in cystic fibrosis.
Elliott RB; Escobar LC; Lees HR; Akroyd RM; Reilly HC
N Z Med J; 1992 Mar; 105(930):107-8. PubMed ID: 1553114
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic enzyme supplementation as acid-resistant microspheres versus enteric-coated granules in cystic fibrosis. A double placebo-controlled cross-over study.
Petersen W; Heilmann C; Garne S
Acta Paediatr Scand; 1987 Jan; 76(1):66-9. PubMed ID: 3551493
[TBL] [Abstract][Full Text] [Related]
8. Comparison of a high lipase pancreatic enzyme extract with a regular pancreatin preparation in adult cystic fibrosis patients.
Gan KH; Heijerman HG; Geus WP; Bakker W; Lamers CB
Aliment Pharmacol Ther; 1994 Dec; 8(6):603-7. PubMed ID: 7696449
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of enteric-coated preparations on nutritional parameters in cystic fibrosis. A long-term study.
Carroccio A; Pardo F; Montalto G; Japichino L; Iacono G; Collura M; Notarbartolo A
Digestion; 1988; 41(4):201-6. PubMed ID: 3243379
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of small vs. large doses of enteric coated pancreatic enzymes in reducing steatorrhea in children with cystic fibrosis: a prospective randomized study.
Brady MS; Rickard K; Yu PL; Eigen H
Pediatr Pulmonol; 1991; 10(2):79-85. PubMed ID: 2030925
[TBL] [Abstract][Full Text] [Related]
11. Comparative trial of viokase, pancreatin and Pancrease pancrelipase (enteric coated beads) in the treatment of malabsorption in cystic fibrosis.
Mitchell EA; Quested C; Marks RE; Pinnock RE; Elliott RB
Aust Paediatr J; 1982 Jun; 18(2):114-7. PubMed ID: 6923744
[No Abstract] [Full Text] [Related]
12. Omeprazole enhances the efficacy of pancreatin (pancrease) in cystic fibrosis.
Heijerman HG; Lamers CB; Bakker W
Ann Intern Med; 1991 Feb; 114(3):200-1. PubMed ID: 1984743
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: Effectiveness of an enteric-coated preparation with and without antacids and cimetidine.
Gow R; Bradbear R; Francis P; Shepherd R
Lancet; 1981 Nov; 2(8255):1071-4. PubMed ID: 6118524
[No Abstract] [Full Text] [Related]
14. Therapeutic potential and clinical efficacy of acid-resistant fungal lipase in the treatment of pancreatic steatorrhoea due to cystic fibrosis.
Zentler-Munro PL; Assoufi BA; Balasubramanian K; Cornell S; Benoliel D; Northfield TC; Hodson ME
Pancreas; 1992; 7(3):311-9. PubMed ID: 1594552
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of enteric coated pancreatic enzymes given before meals in reducing steatorrhea in children with cystic fibrosis.
Brady MS; Rickard K; Yu PL; Eigen H
J Am Diet Assoc; 1992 Jul; 92(7):813-7. PubMed ID: 1624649
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic enzyme replacement therapy: comparative effects of conventional and enteric-coated microspheric pancreatin and acid-stable fungal enzyme preparations on steatorrhoea in chronic pancreatitis.
Schneider MU; Knoll-Ruzicka ML; Domschke S; Heptner G; Domschke W
Hepatogastroenterology; 1985 Apr; 32(2):97-102. PubMed ID: 2408983
[TBL] [Abstract][Full Text] [Related]
17. Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region.
Bruno MJ; Haverkort EB; Tijssen GP; Tytgat GN; van Leeuwen DJ
Gut; 1998 Jan; 42(1):92-6. PubMed ID: 9505892
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic enzyme replacement therapy for people with cystic fibrosis.
Somaraju UR; Solis-Moya A
Cochrane Database Syst Rev; 2014 Oct; (10):CD008227. PubMed ID: 25310479
[TBL] [Abstract][Full Text] [Related]
19. New enteric-coated high-lipase pancreatic extract in the treatment of pancreatic steatorrhea.
Malesci A; Mariani A; Mezzi G; Bocchia P; Basilico M
J Clin Gastroenterol; 1994 Jan; 18(1):32-5. PubMed ID: 8113582
[TBL] [Abstract][Full Text] [Related]
20. Malabsorption in cystic fibrosis: mechanisms and treatment.
Bouquet J; Sinaasappel M; Neijens HJ
J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S30-5. PubMed ID: 3404359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
